281 related articles for article (PubMed ID: 29325012)
1. Systematic review of the cost-effectiveness of transcatheter interventions for valvular heart disease.
Gialama F; Prezerakos P; Apostolopoulos V; Maniadakis N
Eur Heart J Qual Care Clin Outcomes; 2018 Apr; 4(2):81-90. PubMed ID: 29325012
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of transcatheter valvular interventions: economic challenges.
Osnabrugge RL; Kappetein AP; Reynolds MR; Cohen DJ
EuroIntervention; 2013 Sep; 9 Suppl():S48-54. PubMed ID: 24025958
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation.
Orlando R; Pennant M; Rooney S; Khogali S; Bayliss S; Hassan A; Moore D; Barton P
Health Technol Assess; 2013 Aug; 17(33):1-86. PubMed ID: 23948359
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk.
Fairbairn TA; Meads DM; Hulme C; Mather AN; Plein S; Blackman DJ; Greenwood JP
Heart; 2013 Jul; 99(13):914-20. PubMed ID: 23696198
[TBL] [Abstract][Full Text] [Related]
5. Is transcatheter aortic valve implantation (TAVI) a cost-effective treatment in patients who are ineligible for surgical aortic valve replacement? A systematic review of economic evaluations.
Eaton J; Mealing S; Thompson J; Moat N; Kappetein P; Piazza N; Busca R; Osnabrugge R
J Med Econ; 2014 May; 17(5):365-75. PubMed ID: 24611813
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.
Doble B; Blackhouse G; Goeree R; Xie F
J Thorac Cardiovasc Surg; 2013 Jul; 146(1):52-60.e3. PubMed ID: 22795437
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement.
Watt M; Mealing S; Eaton J; Piazza N; Moat N; Brasseur P; Palmer S; Busca R; Sculpher M
Heart; 2012 Mar; 98(5):370-6. PubMed ID: 22076021
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of model-based economic evaluations of heart valve implantations.
Huygens SA; Takkenberg JJM; Rutten-van Mölken MPMH
Eur J Health Econ; 2018 Mar; 19(2):241-255. PubMed ID: 28265822
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of transcatheter versus surgical management of structural heart disease.
Fanari Z; Weintraub WS
Cardiovasc Revasc Med; 2016; 17(1):44-7. PubMed ID: 26440768
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter Aortic Valve Implantation for Treatment of Aortic Valve Stenosis: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(19):1-94. PubMed ID: 27990197
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of TAVR in low-risk patients: do we have more than a NOTION?
Galper BZ; Baron SJ; Cohen DJ
EuroIntervention; 2019 Dec; 15(11):e953-e955. PubMed ID: 31806585
[No Abstract] [Full Text] [Related]
12. Systematic review of the cost-effectiveness of transcatheter aortic valve implantation.
Indraratna P; Ang SC; Gada H; Yan TD; Manganas C; Bannon P; Cao C
J Thorac Cardiovasc Surg; 2014 Aug; 148(2):509-14. PubMed ID: 24280719
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis.
Simons CT; Cipriano LE; Shah RU; Garber AM; Owens DK; Hlatky MA
Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):419-28. PubMed ID: 23838104
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness considerations in transcatheter management of valvular heart disease.
Gadey G; Reynolds MR
Can J Cardiol; 2014 Sep; 30(9):1058-63. PubMed ID: 24999170
[TBL] [Abstract][Full Text] [Related]
15. [Systematic review: Validity and transferability of the results of health-economic evaluations of Transcatheter Aortic Valve Implantation].
Wolf S; Fischer S
Wien Med Wochenschr; 2019 Sep; 169(11-12):293-303. PubMed ID: 30141111
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A).
Reynolds MR; Magnuson EA; Lei Y; Wang K; Vilain K; Li H; Walczak J; Pinto DS; Thourani VH; Svensson LG; Mack MJ; Miller DC; Satler LE; Bavaria J; Smith CR; Leon MB; Cohen DJ;
J Am Coll Cardiol; 2012 Dec; 60(25):2683-92. PubMed ID: 23122802
[TBL] [Abstract][Full Text] [Related]
17. Transfemoral, transapical and transcatheter aortic valve implantation and surgical aortic valve replacement: a meta-analysis of direct and adjusted indirect comparisons of early and mid-term deaths.
Ando T; Takagi H; Grines CL
Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):484-492. PubMed ID: 28549125
[TBL] [Abstract][Full Text] [Related]
18. Cost-analysis of percutaneous pulmonary valve implantation compared to surgical pulmonary valve replacement.
Vergales JE; Wanchek T; Novicoff W; Kron IL; Lim DS
Catheter Cardiovasc Interv; 2013 Dec; 82(7):1147-53. PubMed ID: 23857801
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter Aortic Valve Implantation in Lower-Risk Patients With Aortic Stenosis: Is It Justified to Be the Preferred Treatment?
Abdelghani M; Serruys PW
Circ Cardiovasc Interv; 2016 Apr; 9(4):e002944. PubMed ID: 27076570
[TBL] [Abstract][Full Text] [Related]
20. Cardiac rehabilitation programme after transcatheter aortic valve implantation versus surgical aortic valve replacement: Systematic review and meta-analysis.
Ribeiro GS; Melo RD; Deresz LF; Dal Lago P; Pontes MR; Karsten M
Eur J Prev Cardiol; 2017 May; 24(7):688-697. PubMed ID: 28071146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
